bioRxivImmunologyPreprint
Schistosoma mansoni infection reprograms the metabolic potential of the myeloid lineage in a mouse model of metabolic syndrome
D. Cortes-Selva, L. Gibbs, J. A. Maschek, T. Van Ry, B. Rajwa, J. E. Cox, E. Amiel, K. C. Fairfax
Abstract
Despite evidence that helminths protect from metabolic disease, a major gap exists in understanding the underlying mechanism(s). Here we demonstrate that bone marrow derived macrophages (BMDM) from S. mansoni infected male ApoE-/- mice have dramatically increased mitochondrial respiration compared to those from uninfected mice. This change associates with increased glucose and palmitate shuttling into TCA cycle intermediates and decreased accumulation of cellular cholesterol esters. Moreover, systemic metabolic modulation by schistosomes is a function of biological sex, where infection protects ApoE-/- male, but not female, mice from obesity and glucose intolerance. Sex-dependence extends to myeloid cells, where reprogramming leads to opposite cholesterol phenotypes in BMDM from females and males. Finally, the metabolic reprogramming of male myeloid cells is transferrable via bone marrow transplantation to an uninfected host, indicating maintenance of reprogramming in the absence of sustained antigen exposure. This work reveals that S. mansoni systemic reprograming of myeloid metabolism is sex-dependent.
- organism: mouse
- assay: metabolomics
- assay: proteomics
- research focus: metabolism & bioenergetics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Schistosoma mansoni antigen induced innate immune memory features mitochondrial biogenesis and can be inhibited by ovarian produced hormones
Juan Marcos Oviedo, Diana Cortés‐Selva, … Keke C. Fairfax·bioRxiv·Jan 14, 2025
- Schistosoma mansoni does not and cannot oxidize fatty acids, but these are used for biosynthetic purposes instead
M. L. Bexkens, M. M. Mebius, … J. J. van Hellemond·bioRxiv·Nov 6, 2018
- Schistosoma mansoni-induced host immunopathology is gut microbiota dependent
Anna O. Kildemoes, Gabriele Schramm, … Birgitte Jyding Vennervald·bioRxiv·Jan 24, 2025
- Comparative metabonomic investigations of Schistosoma japonicum from SCID mice and BALB/c mice: clues to developmental abnormality of schistosome in the immunodeficient host
R. Liu, W.-J. Cheng, … H. F. Dong·Frontiers in MicrobiologyPeer-reviewed·Mar 12, 2019
- Helminth infection impacts hematopoiesis
T. Wijshake, J. Wang, … M. Agathocleous·bioRxiv·Feb 10, 2023
- Tissue-specific distribution of eggs in the definitive host drives transcriptomic and behavioral differences in Schistosoma mansoni miracidia
Sophie Willett, Sonja A. Olson, … Nicolas James Wheeler·bioRxiv·Aug 15, 2025